Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 09, 2026 07:00 ET | Source: MitoRx Therapeutics Limited

MitoRx Therapeutics Strengthens Leadership Team with C-Suite and Board Appointments to Support Next Phase of Growth

Alison Strutt appointed as Chief Financial Officer, László Tankó appointed as Consultant Chief Medical Officer, and Sam Fazeli appointed Non-Executive DirectorAppointments support MitoRx’s next phase...
June 08, 2026 07:00 ET | Source: MitoRx Therapeutics Limited

MitoRx Therapeutics presents promising preclinical data on MTRX31, a mitochondrial-targeted small molecule for metabolically unhealthy obesity, at the American Diabetes Association’s 2026 Scientific Sessions

MTRX31 led to a highly significant decrease in fat mass after two-months chronic dosing in a preclinical diet-induced obesity mouse model performed at thermoneutrality Weight loss and reduction of fat...
June 03, 2026 08:00 ET | Source: Lexicon Pharmaceuticals, Inc.

Lexicon to Present Data at the American Diabetes Association (ADA) 2026 Scientific Sessions

THE WOODLANDS, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it will present data from clinical studies of sotagliflozin in Type 1...
June 02, 2026 02:00 ET | Source: Lucera GmbH

Launch of TechBio firm, Lucera, brings decision intelligence to drug development, making it more predictable, more evidence-grounded, and more efficient

Launch of TechBio firm, Lucera, brings decision intelligence to drug development, making it more predictable, more evidence-grounded, and more efficient Well-established pharmaceutical technology...
May 28, 2026 08:30 ET | Source: Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference

THE WOODLANDS, Texas, May 28, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 2026 Jefferies...
May 25, 2026 20:00 ET | Source: AGC Biologics, Inc.

AGC Biologics to Manufacture Teikoku Seiyaku's rhMMP-7 Drug Substance

AGC Biologics will provide contract development and manufacturing services for Teikoku Seiyaku’s drug candidate to treat lumbar disc herniation.
May 25, 2026 06:02 ET | Source: Research and Markets

Biosimulation Market Research Report 2026 2026-2035: Personalized Medicine, AI Integration, and Subscription Models Drive Innovations

Dublin, May 25, 2026 (GLOBE NEWSWIRE) -- The "Biosimulation Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering....
May 19, 2026 08:00 ET | Source: Science 37, Inc.

Science 37 and Tufts CSDD Publish Landmark Study on Direct-to-Patient Clinical Trial Site Performance, Outperforming Industry Benchmarks

Tufts CSDD completes peer-reviewed analysis of Science 37’s Direct-to-Patient Clinical Trial Site, comparing performance to industry benchmarks.
May 19, 2026 06:30 ET | Source: Avance Clinical

Avance Clinical to Showcase Oncology Leadership at ASCO Annual Meeting 2026

Meet Avance Clinical's Oncology Center of Excellence expert team at ASCO Annual Meeting in Chicago, held 29 May – 2 June 2026.
May 15, 2026 07:39 ET | Source: Research and Markets

Tetraspecific Antibodies Clinical Pipeline Market research 2026: Development Technologies, Therapeutic Approaches & Market Opportunity Insight to 2032

Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "Tetraspecific Antibodies Clinical Pipeline, Development Technologies, Therapeutic Approaches & Market Opportunity Insight 2026" report has been...